Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors

Affiliations

Julie L Ryan et al. Radiat Res. 2011 Nov.

. 2011 Nov;176(5):688-91.

doi: 10.1667/rr2704.1. Epub 2011 Sep 1.

¹ Departments of Dermatology & Radiation Oncology, University of Rochester Medical Center, Rochester, New York 14642, USA. Julie_Ryan@urmc.rochester.edu

No abstract available

Figures

Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.
Rivina L, Schiestl R. Rivina L, et al. Int J Environ Res Public Health. 2012 Dec 27;10(1):107-43. doi: 10.3390/ijerph10010107. Int J Environ Res Public Health. 2012. PMID: 23271302 Free PMC article. Review.
Amifostine Prophylaxis in Irradiated Breast Reconstruction: A Study of Oncologic Safety In Vitro.
Luby AO, Subramanian C, Buchman LK, Lynn JV, Urlaub KM, Nelson NS, Donneys A, Cohen MS, Buchman SR. Luby AO, et al. Ann Plast Surg. 2020 Oct;85(4):424-429. doi: 10.1097/SAP.0000000000002110. Ann Plast Surg. 2020. PMID: 31850964 Free PMC article.
2013 Dade W. Moeller lecture: medical countermeasures against radiological terrorism.
Moulder JE. Moulder JE. Health Phys. 2014 Aug;107(2):164-71. doi: 10.1097/HP.0000000000000082. Health Phys. 2014. PMID: 24978287 Free PMC article. Review.
Ionizing radiation: the good, the bad, and the ugly.
Ryan JL. Ryan JL. J Invest Dermatol. 2012 Mar;132(3 Pt 2):985-93. doi: 10.1038/jid.2011.411. Epub 2012 Jan 5. J Invest Dermatol. 2012. PMID: 22217743 Free PMC article. Review.
Vitamin E Analogs as Radiation Response Modifiers.
Singh PK, Krishnan S. Singh PK, et al. Evid Based Complement Alternat Med. 2015;2015:741301. doi: 10.1155/2015/741301. Epub 2015 Aug 20. Evid Based Complement Alternat Med. 2015. PMID: 26366184 Free PMC article. Review.

1. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS, Barcellos-Hoff MH, Dynan WS, Fike JR, Grdina DJ, Greenberger JS, Hauer-Jensen M, Hill RP, Kolesnick RN, Macvittie TJ, Marks C, McBride WH, Metting N, Pellmar T, Purucker M, Robbins ME, Schiestl RH, Seed TM, Tomaszewski JE, Travis EL, Wallner PE, Wolpert M, Zaharevitz D. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3–4, 2003. Radiat Res. 2004 Dec;162(6):711–28. - PubMed
1. Patt HM, Mayer SH, Straube RL, Jackson EM. Radiation dose reduction by cysteine. J Cell Physiol. 1953 Dec;42(3):327–41. - PubMed
1. Cassatt DR, Kaminski JM, Hatchett RJ, DiCarlo AL, Benjamin JM, Maidment BW. Medical countermeasures against nuclear threats: radionuclide decorporation agents. Radiat Res. 2008 Oct;170(4):540–8. - PMC - PubMed
1. DiCarlo AL, Hatchett RJ, Kaminski JM, Ledney GD, Pellmar TC, Okunieff P, Ramakrishnan N. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26–27, 2007. Radiat Res. 2008 Jun;169(6):712–21. - PMC - PubMed
1. Dumont F, Le Roux A, Bischoff P. Radiation countermeasure agents: an update. Expert Opin Ther Pat. 2010 Jan;20(1):73–101. - PubMed